Drug-eluting coronary stents for treating coronary artery disease: late-stage assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 28 March 2025
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Optical Coherence Tomography to guide percutaneous coronary interventionStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and living with overweight or obesity ID6441Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC